A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer

Clinical trial NCT06184035 · RECRUITING

Trial details

NCT number: NCT06184035
Sponsor: Spago Nanomedical AB
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Metastatic Cancer Unresectable Solid Tumor Recurrent Solid Tumor Locally Advanced Solid Tumor Refractory Cancer

Start date: 2023-12-06
Primary completion: 2027-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.